In Alzheimer's disease (AD), AnxA1 offers protection against AD by degradation and clearance of β-amyloid (Aβ) and reducing neuroinflammation, making it a potential therapeutic option in AD (149). The gene discussed is ANXA1; the disease is Alzheimer disease.